Matrisome Bio
PrivateLast Round
Grant
Sep 2, 2025
Total Funding Raised
$1.59M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Matrisome Bio is a biotechnology company developing a therapeutic platform that uses nanobodies to target the extracellular matrix for the treatment of cancer and other chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Matrisome Bio Comparables
Compare Matrisome Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Engitix Therapeutics | 82% | |
| Tandem Therapeutics AG | 79% | |
| Albatroz Therapeutics | 78% |
Matrisome Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 2, 2025 |
Matrisome Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Pacific 8 Ventures | Seed |
| Engine Ventures | Seed |
| NIH RADx | Grant |
| BOLD Capital Partners | Seed |
| Endless Frontier Labs | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 303% MoM, reaching 677.
- Apr 1, 2026
Monthly visitors grew 583% MoM.
Matrisome Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Matrisome Bio's valuation, stock price, and market status.
Is Matrisome Bio a public or private company?
Matrisome Bio is a private company.
What is the current stock price of Matrisome Bio?
Matrisome Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Matrisome Bio worth (valuation)?
Valuation information for Matrisome Bio is not publicly available.
Can I buy Matrisome Bio stock?
Matrisome Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Matrisome Bio's last funding round?
Matrisome Bio's most recent funding round was Grant on September 2, 2025.
Who are the main investors in Matrisome Bio?
Key investors in Matrisome Bio include National Cancer Institute, Engine Ventures.
Will Matrisome Bio IPO soon?
No public IPO plans have been announced for Matrisome Bio.
How can I track Matrisome Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Matrisome Bio's secondary market activity and sign up for updates.